RBC Capital raised the firm’s price target on Galapagos (GLPG) to $32 from $28 and keeps a Sector Perform rating on the shares. The firm is citing better than expected cost/interest structure, along with increased Gilead (GILD) amenability to recast Galapagos economics, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLPG:
- Galapagos NV Reports Strategic Shift and Financial Results
- Galapagos NV Earnings Call: Strategic Shifts Amid Challenges
- Galapagos NV to Wind Down Cell Therapy Business Amid Strategic Shift
- Galapagos to Present Promising CAR-T Cell Therapy Data at ASH 2025
- GLPG Upcoming Earnings Report: What to Expect?